tiprankstipranks

Walsh Colin Insider Profile

4 Followers
Walsh Colin, Director at Attovia Therapeutics, Inc., holds 3.02M shares in Attovia Therapeutics, Inc. (Ticker: ATTO), holds ― shares in Elevation Oncology (Ticker: ELEV). Most recently, Walsh Colin Bought ― shares of Attovia Therapeutics, Inc. on Aug 13, 2026 for an estimated value of $10.29M.
tipranks
Walsh Colin

Walsh Colin
Attovia Therapeutics, Inc. (ATTO)
Director

Ranked #69,996 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-16.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$77M
100.00%
A breakdown of Walsh Colin's holdings

Insider Roles

Attovia Therapeutics, Inc.
(ATTO)
Director
Roles that Walsh Colin holds in companies

Most Profitable Insider Trade

Stock:
Attovia Therapeutics, Inc.
(ATTO)
Rating:Informative Buy
Date:Aug 13, 2026 - Today
Return:0.00%
The most profitable trade made by Walsh Colin

Walsh Colin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Attovia Therapeutics, Inc.
Aug 13, 2026
Director
Informative Buy
10.29M
$77.18M
ELEV
Elevation Oncology
List of latest transactions for each holding click on a transaction to see Walsh Colin's performance on stock

Walsh Colin insider profile FAQ

What is the percentage of profitable transactions made by Walsh Colin?
The percentage of profitable transactions made by Walsh Colin is 0%.
    What is the average return per transaction made by Walsh Colin?
    The average return per transaction made by Walsh Colin is -16.60%.
      What stocks does Walsh Colin hold?
      Walsh Colin holds: ATTO, ELEV stocks.
        What was Walsh Colin’s latest transaction?
        Walsh Colin latest transaction was an Informative Buy of $10.29M.
          What was Walsh Colin's most profitable transaction?
          Walsh Colin’s most profitable transaction was an Informative Buy of ATTO stock on August 13, 2026. The return on the trade was 0.00%.
            What is Walsh Colin's role in Attovia Therapeutics, Inc.?
            Walsh Colin's role in Attovia Therapeutics, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.